Intelligence

#In vitro #In vitro assays #iPSC #Neuroscience

Development of robust co-culture models with human iPSC-derived microglia and excitatory neurons

Download this Application Note to learn more about: Co-culture methods for ioMicroglia with wild type and disease model ioGlutamatergic Neurons. Assay optimisation for a live cell in vitro neuronal activity assay. Solutions for visualisation and quantification of changes in co-culture health, morphology, function and marker expression. Read More

#Resources

#Genetically engineered models (GEMs) #Mouse models #Preclinical investigations

Optimise your preclinical research with genetically engineered mouse models

This guide explores key considerations for generating and managing genetically engineered mouse models (GEMs) to accelerate and optimise preclinical research programmes. Generating GEMs: three cutting-edge technologies you need to know. Five key components of effective colony management. How integrated solutions can unlock the full potential of preclinical research. Read More

#Resources

Machine learning concept
#Artificial intelligence (AI) #Financing #Oncology #Orakl Oncology #Spinout #Start-ups

€11m supports launch of AI-powered drug development platform

Orakl Oncology has announced an €11 million seed funding round, led by Singular, with support from Bpifrance including the Grand Prix i-Lab, and participation from existing investors.   The new funding will be used to accelerate the company’s growth and support the launch of two new commercial products,… Read More

#Business & Investment #News #Start-up Zone

#Amyotrophic lateral sclerosis (ALS) #Human disease models #iPSC #Neuroscience

Disease modelling with genetically matched iPSC-derived excitatory neurons

Download bit.bio’s application note to learn more about: Functional characterisation of human iPSC-derived ALS disease models using high throughput MEA. Phenotypic data showing reduced neuronal activity and network formation in ALS disease models. A genetically matched system in ioGlutamatergic Neurons that can be used to identify, measure and rescue disease-related… Read More

#Resources

#Drug discovery

eBook: Optimize Your Preclinical Research with Genetically Engineered Mouse Models

This guide explores key considerations for generating and managing genetically engineered mouse models (GEMs) to accelerate and optimize preclinical research programs. Generating GEMs: three cutting-edge technologies you need to know. Five key components of effective colony management. How integrated solutions can unlock the full potential of preclinical research. Read More

#eBooks

#Drug discovery

App Note: Development of robust co-culture models with human iPSC-derived microglia and excitatory neurons

Download this application note to learn more about: Co-culture methods for ioMicroglia with wild type and disease model ioGlutamatergic Neurons. Assay optimisation for a live cell in vitro neuronal activity assay. Solutions for visualisation and quantification of changes in co-culture health, morphology, function and marker expression.  … Read More

#App Notes

#Neuroscience

App Note: Disease modelling with genetically matched iPSC-derived excitatory neurons

Download bit.bio’s application note to learn more about: Functional characterisation of human iPSC-derived ALS disease models using high throughput MEA. Phenotypic data showing reduced neuronal activity and network formation in ALS disease models. A genetically matched system in ioGlutamatergic Neurons that can be used to identify, measure and rescue disease-related… Read More

#App Notes

#Automation / robotics

Case Study: Automating Cell-Based Assays to Determine Viral Vector Titer

In this Case Study, Oxford Biomedica, an innovative global gene and cell therapy company, describes: The automated system used for a 10-day cell-based workflow required for an analytical test to determine viral vector titer The advantages of Hamilton’s CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays… Read More

#Case Studies

#Humanised Immune System (HIS) #In vivo #Mouse models #Preclinical development

Unlocking drug discovery with humanized immune system mouse models

Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics. Our whitepaper delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions. You will learn about: The significance of HIS models in bridging the… Read More

#Resources

#Artificial intelligence (AI) #Drug discovery #In Focus Report #Machine learning #Market reporting

AI and ML: How technology is improving drug discovery

Created by DDW and sponsored by Benchling, ‘AI & ML: How technology is improving drug discovery’ is a free In Focus report available to download now. Artificial intelligence (AI) and machine learning (ML) are helping drive efficiencies across drug discovery and development processes and represent exciting tools that teams can… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Financing #Oncology #Radioligand Therapies (RLTs) #Radiopharmaceuticals #Starget Pharma #Start-ups

Starget secures $5.1m for clinical trial of targeted cancer therapy

Start-up Starget Pharma has raised $5.1 million in funding to support development of its radioligand-based therapies that target tumour cells with focused radiation. The investment was secured from Cancer Focus, a fund established in collaboration with the MD Anderson Cancer Center at the University of Texas. Read More

#Business & Investment #News #Start-up Zone

#Artificial intelligence (AI) #Automation / robotics #Intrepid Labs #Spinout #Start-ups

Canadian start-up looking to boost drug development success rates

Dr Christine Allen, Co-Founder and CEO of Intrepid Labs tells Lu Rahman why the company’s technology has the ability to streamline the drug development process and improve the success rate of getting drugs to market. Intrepid Labs is the first spin-off from the University of Toronto’s Acceleration Consortium, which received… Read More

#Exclusive Content #Start-up Zone

#Lab equipment #Lab technology #Laboratory #Sample preparation

Reduce costs, while continuing to safeguard samples, by raising the setpoint for ULT freezers from –80°C to –70°C

Download this Smart Note to learn more about: Energy savings: Discover how setting your Thermo Scientific™ TSX™ Universal Series ULT freezers to –70°C can help reduce energy consumption by up to 37% Sample integrity: Learn why most biological samples, including crucial nucleic acids, bacteria, and viruses, remain stable at –70°C… Read More

#Resources

#ADME / Tox #Biopharmaceuticals #Drug toxicity #Endotoxins

EtoxiClear®: Optimising endotoxin removal

In this Technical Note you will learn more about: Targeted and efficient endotoxin removal: EtoxiClear® is a highly effective chromatography affinity adsorbent, specifically designed to remove low residual levels of endotoxins across a variety of biopharmaceutical processes, ensuring high product purity Scalability and cost-effectiveness: Designed for both small and large-scale… Read More

#Resources

Case Study: Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation
#3D cell culture #Automation #Automation / robotics #Cell Science #In vitro

Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation

In this Case Study, InSphero, a Swiss-based company specialising in 3D in vitro cell models and cell culture tools for drug discovery, describes: The advantages of 3D in vitro cell models for drug discovery The automation of the production of 3D in vitro cell models via InSphero’s Akura™ technology The… Read More

#Resources